banda transcan 2 2016ul

The launched and completed Joint Transnational Calls (JTC), in translational cancer research, are seven.

 

Three of them were launched and implemented under the previous TRANSCAN project:

JTC 2011  launched on December 2011 on: "Validation of biomarkers for personalised cancer medicine", 10 projects funded

JTC 2012  launched on December 2012 on: “Translational research on primary and secondary prevention of cancer”, 10 projects funded

JTC 2013  launched on December 2013 on: "Translational research on tertiary prevention in cancer patients", 10 projects funded

 

The ongoing TRANSCAN-2 project has launched all four calls planned:

JTC 2014 (co-funded by the European Commission)  launched on January 2015 on: "Translational research on human tumour heterogeneity to overcome recurrence and resistance to therapy", 16 projects funded

JTC 2015  launched on December 2015 on: “Immunology and immunotherapy of cancer: strengthening the translational aspects”, 7 projects funded

JTC 2016 launched on December 2016 on: "Minimally and non-invasive methods for early detection and/or progression of cancer", 14 projects funded

JTC 2017 launched on December 2017 on "Translational research on rare cancers". 12 projects funded


TRANSCAN News

 TRANSCAN-3 news on:
twitter logoinkedin social media logo

TRANSCAN-3   JOINT TRANSNATIONAL CALL 2022 on:
 "Novel translational approaches to tackle the challenges of hard-to-treat cancers from early diagnosis to therapy"  

is open for submission

Please visit the TRANSCAN-3 website at
https://transcan.eu/funding/calls/joint-call-jtc-2022-.kl


Other news:

The Digital Institute for Cancer Outcomes Research (DIGICORE),  is delighted to announce an innovative new training programme for early career researchers in oncology: IDEAL4RWE.
 Please register for an introductory webinar on the19th April 2022(https://lnkd.in/ez7y4kWU).
Brochure for more details: https://tinyurl.com/y7aurdtk


 The first TRANSCAN-3 call (JTC 2021) on:
"Next generation cancer immunotherapy: targeting the tumour microenvironment"
is closed for submission

International Networking Event (virtual)
on 22 April 2021 hrs 9:00 CET
will focus on the forthcoming co-funded JTC 2021 on:
"Next generation cancer immunotherapy: targeting the tumour microenvironment" 
the event is organized by TUBITAK under the “Turkey in Horizon 2020 Phase II” Technical Assistance Project
in cooperation with TRANSCAN-3

The new ERA-NET Cofund TRANSCAN-3:
 Sustained collaboration of national and regional programmes in cancer research
is funded by the European Commission under H2020  which started on 1st March 2021 and will last five years (G. A. no. 964264)

A TRANSCAN-2 brochure, highlighting key achievements, is available for download

 

Newsletters

The TRANSCAN-3 newsletters are published at: https://www.transcan.eu/

SUBSCRIBE to the newsletters
You can unsubscribe at any moment by clicking on the subscription preferences link at the bottom of a received newsletter


All the TRANSCAN-2 newsletters:

Newsletter 10, Sept.2020
Newsletter 9, Dec.2019

Newsletter 8, May 2019
Newsletter 7, Oct.2018
Newsletter 6, June 2108
Newsletter 5, March 2018
Newsletter 4, Dec. 2017
Newsletter 3, Sept. 2017
Newsletter 2, April 2017
Newsletter 1, Dec. 2016

eu flagship

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 643638.

Who's Online

We have 8 guests and no members online